Urinary Incontinence Poses Burden to Long-Term Care
MONDAY, July 25, 2022 -- The impact and management of urinary incontinence (UI) related to overactive bladder is a substantial burden to long-term care (LTC) residents and staff, according to a study published online July 1 in the Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 25, 2022 Category: Pharmaceuticals Source Type: news
Published Studies Find Low Documented Adherence to Guideline-Based Care for Female Urinary Incontinence
Low adherence associated with higher costs for payers
BOSTON, July 22, 2022 -- (Healthcare Sales & Marketing Network) -- Renovia Inc. (Renovia), a developer of non-surgical treatments for female pelvic floor disorders and an advocate for women's health... Devices, Urology Renovia, leva Pelvic Health System (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 22, 2022 Category: Pharmaceuticals Source Type: news
Are these Britain's most sexist surgeons?
Carole, 76, a mother of one from Stevenage, Hertfordshire, had endured weeks of agony after an NHS surgeon had inserted a polypropylene mesh implant to treat a slight incontinence problem. (Source: the Mail online | Health)
Source: the Mail online | Health - July 19, 2022 Category: Consumer Health News Source Type: news
Renovia receives FDA clearance for leva(R) Pelvic Health System as first-line treatment for chronic fecal incontinence
Clearance for new indication follows FDA Breakthrough Device Designation
BOSTON, July 7, 2022 -- (Healthcare Sales & Marketing Network) -- Renovia Inc. ("Renovia"), a developer of non-surgical, treatments for female pelvic floor disorders and... Devices, FDA Renovia , leva Pelvic Health, fecal incontinence (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 7, 2022 Category: Pharmaceuticals Source Type: news
Pelvic floor disorder awareness
The pelvic floor is a group of muscles that run across the bottom of the pelvis and hold up various organs, including the bladder and bowel. Weakening of the muscles or connective tissues in the pelvic floor can cause issues such as urinary or fecal incontinence or organ prolapse. One of the biggest misconceptions about pelvic floor disorders is that they only affect women after a pregnancy. "Pregnancy can contribute to pelvic floor disorders, but… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - June 30, 2022 Category: Databases & Libraries Source Type: news
YUN Training With Pelvic Floor Magnetic Stimulation Efficacy YUN Training With Pelvic Floor Magnetic Stimulation Efficacy
Is this combination strategy an effective option for the treatment of female stress urinary incontinence and sexual function?Translational Andrology and Urology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 24, 2022 Category: Consumer Health News Tags: Urology Journal Article Source Type: news
Remote Workouts May Ease Urinary Incontinence Remote Workouts May Ease Urinary Incontinence
In a pilot study, mostly premenopausal women who completed 8 weeks of video-guided pelvic floor exercises reported less leakage and improved symptoms.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 21, 2022 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news
Understanding approaches to continence care for people living with dementia in acute hospital settings: an ethnographic study
This study found continence care was often deprioritised to reduce interruptions to ward timetables, establishing ' pad cultures ' negatively impacting individuals and reliant on placing incontinence pads on continent older people. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 21, 2022 Category: Consumer Health News Source Type: news
Do levels of self-efficacy affect urinary incontinence, falls, quality of life, sleep, and physical activity in elderly people with urinary incontinence? - Ba şer Seçer M, Çeliker Tosun, Tosun G.
BACKGROUND: Our study aims to determine whether different self-efficacy (SE) levels affect urinary incontinence symptoms, falls, quality of life, sleep, and physical activity in elderly individuals with incontinence. Our secondary aim is to examine the rel... (Source: SafetyLit)
Source: SafetyLit - June 20, 2022 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news
Consumer Health: Gentlemen, are you doing your Kegels?
June is Men's Health Month, which makes this a good time to learn more about the benefits of Kegels for men. Kegel exercises, also known as pelvic floor muscle training, can prevent or control urinary incontinence and other pelvic floor problems. For women, Kegel exercises may be suggested for some incontinence problems, including during pregnancy and after childbirth. But Kegels aren't just for women. For men, Kegel exercises can strengthen the pelvic floor muscles, which… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - June 17, 2022 Category: Databases & Libraries Source Type: news
Surgeons May Underestimate Recovery From Incontinence Operation Surgeons May Underestimate Recovery From Incontinence Operation
An analysis found no way to predict which patients will take longer to return to work and other activities after midurethral sling procedures.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 13, 2022 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news
Longer-term Data from CARTITUDE-1 Study Demonstrate Continued Deep and Durable Responses to CARVYKTI ™ (ciltacabtagene autoleucel) in Heavily Pretreated Patients with Relapsed or Refractory Multiple Myeloma
CHICAGO, ILLINOIS, June 4, 2022 – – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today updated results from the Phase 1b/2 CARTITUDE-1 study evaluating the efficacy and safety of CARVYKTI™ (ciltacabtagene autoleucel; cilta-cel), a B-cell maturation antigen (BCMA)-directed chimeric antigen receptor T-cell (CAR-T) therapy. The study included patients with relapsed or refractory multiple myeloma (RRMM) who had received >3 lines of therapy including a proteasome inhibitor (PI), an anti-CD38 monoclonal antibody and an immunomodulatory agent (IMiD) or were double refractory to an IMiD and PI a...
Source: Johnson and Johnson - June 4, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news
Janssen to Highlight Science, Innovation and Advances in Robust Oncology Portfolio and Pipeline Through More Than 60 Data Presentations at ASCO and EHA
RARITAN, N.J., May 31, 2022 — The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that new research and data from its robust oncology portfolio and pipeline of investigational therapies will be presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place June 3-7 in Chicago, and the European Hematology Association (EHA) 2022 Congress taking place in Vienna, Austria, June 9-12. More than 60 presentations from company-sponsored studies across the two congresses, including 14 oral presentations, will feature new data and updates for both approved and investigation...
Source: Johnson and Johnson - May 31, 2022 Category: Pharmaceuticals Source Type: news
Thinx names new CEO
Thinx Inc, a New York company that makes reusable period and incontinence underwear, has appointed Meghan Davis as its chief executive officer.
Current CEO Maria Molland will step down June 30 to spend time with her young children, the company announced.
In a LinkedIn post, Molland said she made the decision to leave the company after multinational consumer goods company Kimberly Clark (NYSE: KMB), maker of brands including Kotex and Dep end, agreed in February to acquire a majority stake in Thinx… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 26, 2022 Category: American Health Authors: Anne Stych Source Type: news
Thinx names new CEO
Thinx Inc, a company that makes reusable period and incontinence underwear, has appointed Meghan Davis as its chief executive officer.
Current CEO Maria Molland will step down June 30 to spend time with her young children, the company announced.
In a LinkedIn post, Molland said she made the decision to leave the company after multinational consumer goods company Kimberly Clark (NYSE: KMB), maker of brands including Kotex and Dep end, agreed in February to acquire a majority stake in Thinx for an… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 26, 2022 Category: Pharmaceuticals Authors: Anne Stych Source Type: news
